TY - JOUR
T1 - EuReCa TWO A prospective observational analysis over three month in cardiac arrest and resuscitation registries in 29 European countries
AU - Wnent, Jan
AU - Masterson, Siobhán
AU - Gräsner, Jan Thorsten
AU - Böttiger, Bernd W.
AU - Eggeling, Johanna
AU - Herlitz, Johan
AU - Koster, Rudolph W.
AU - Lefering, Rolf
AU - Maurer, Holger
AU - Ortiz, Fernando Rosell
AU - Perkins, Gavin D.
AU - Tjelmeland, Ingvild
AU - Bossaert, Leo
N1 - Funding Information:
The EuReCa TWO study is funded by the ERC and the national resuscitation registries or institutes conducting the study.
Funding Information:
The authors express their thanks for support to the European Resuscitation Council (ERC) and the ERC research NET.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2017/9
Y1 - 2017/9
N2 - EuReCa ONE was a one-month survey of epidemiology, treatment and out- come of patients suffering an out-ofhospital cardiac arrest (OHCA), across 27 European nations, in October 2014. The EuReCa ONE study showed a high degree of variation in incidence and outcome across Europe and raised questions about the cause of these variations. For example, different interpretations of the term bystander CPR was noted and confirmed by a subsequent European survey. The need to further understand the cause of variation led to the establishment of the EuReCa TWO project. EuReCa TWO has three primary aims: 1) Expand the EuReCa network; 2) Improve the understanding of the role, age and gender profile of bystanders in OHCA in Europe; 3) Generate estimates of European OHCA incidence and out- come for all patients as well as subgroups that make up a small proportion of overall cases at national level, e.g. traumatic aetiology, patients transferred to hospital with ongoing CPR. In order to achieve these aims, the following objectives will be fulfilled: Encourage participating countries to aim for national data collection and encourage additional countries to participate in the study; increase the data collection period in order to provide more robust estimates of incidence, management and outcome; identify consistency and variation in the use of the term 'bystander CPR'; describe the incidence of 'bystander CPR' and its influence on OHCA outcome. With 29 countries now part of the EuReCa 'family', the EuReCa TWO study will use an expanded Utstein-based dataset and data collection tool over a three-month data collection period for all participating countries. The EuReCa TWO study is registered by ClinicalTrials. gov (ClinicalTrials.gov, Registration Number: NCT03130088).
AB - EuReCa ONE was a one-month survey of epidemiology, treatment and out- come of patients suffering an out-ofhospital cardiac arrest (OHCA), across 27 European nations, in October 2014. The EuReCa ONE study showed a high degree of variation in incidence and outcome across Europe and raised questions about the cause of these variations. For example, different interpretations of the term bystander CPR was noted and confirmed by a subsequent European survey. The need to further understand the cause of variation led to the establishment of the EuReCa TWO project. EuReCa TWO has three primary aims: 1) Expand the EuReCa network; 2) Improve the understanding of the role, age and gender profile of bystanders in OHCA in Europe; 3) Generate estimates of European OHCA incidence and out- come for all patients as well as subgroups that make up a small proportion of overall cases at national level, e.g. traumatic aetiology, patients transferred to hospital with ongoing CPR. In order to achieve these aims, the following objectives will be fulfilled: Encourage participating countries to aim for national data collection and encourage additional countries to participate in the study; increase the data collection period in order to provide more robust estimates of incidence, management and outcome; identify consistency and variation in the use of the term 'bystander CPR'; describe the incidence of 'bystander CPR' and its influence on OHCA outcome. With 29 countries now part of the EuReCa 'family', the EuReCa TWO study will use an expanded Utstein-based dataset and data collection tool over a three-month data collection period for all participating countries. The EuReCa TWO study is registered by ClinicalTrials. gov (ClinicalTrials.gov, Registration Number: NCT03130088).
UR - http://www.scopus.com/inward/record.url?scp=85028937665&partnerID=8YFLogxK
U2 - 10.19224/ai2017.506
DO - 10.19224/ai2017.506
M3 - Journal articles
AN - SCOPUS:85028937665
SN - 0170-5334
VL - 58
SP - 506
EP - 511
JO - Anasthesiologie und Intensivmedizin
JF - Anasthesiologie und Intensivmedizin
IS - 9
ER -